All patents, patent applications, and publications cited within this application are incorporated herein by reference to the same extent as if each individual patent, patent application or publication was specifically and individually incorporated by reference.
The invention relates generally to surface plasmon resonance substrates and associated methods of analyzing biomolecules. In order to analyze a DNA using surface plasmon resonance (SPR) detection, a metal such as gold having a certain thickness is required on the substrate. For application where DNA is deposited on top of gold there is the problem that gold coated glass slides have not been able to survive DNA printing processes that require corrosive oxidizers, with the gold delaminating from the surface. The gold surface must be modified by using different functionalities, the most popular being thiol chemistry. However, the Au—S bonds are vulnerable to aggressive oxidizers used for some DNA printing process. Thus, there is a need for SPR slides that are able to withstand strong oxidizers used in some DNA printing processes.
One embodiment is an article comprising: a) a substrate; b) a first metal film overlying the substrate; c) a second thin metal film, the second thin metal film having a first surface facing the first metal film, and a second surface opposed to the first surface; and d) a reactive organosilane covalently bonded to the second surface of the second thin metal film through metal-oxygen-silicon bonds. The second surface opposed to the first surface in the second thin metal film is hereafter referred to as the “upper” surface of the second thin metal film. The first metal film may be gold, silver, or copper and the second thin metal film may be Ti, Zr, Al, Cr, Hf, V, Ta, W, or Pb. Typically, the first metal film can generate surface plasmons and the upper surface of the second thin metal film is used to form chemically stable bonds to the reactive organosilane. As used herein the second thin metal film is sufficiently thin so as to allow extension of an evanescent plasmon wave from said first metal film. The resulting chips can be cleaned with aggressive oxidizers and biomolecules such as DNA, RNA, or proteins can be printed on the reactive organosilane. Chemical interactions with the printed DNA, RNA, or proteins can then be monitored through surface plasmon resonance methods. The second thin metal film may also generate surface plasmons that may interact with the surface plasmons or with surface plasmon effects from the first metal film.
Another embodiment is a process comprising: a) depositing a first metal film on a substrate; b) depositing a second thin metal film on the first metal film; c) converting the upper surface of the second thin metal film to the corresponding metal oxide; and d) reacting a functionalized organosilane with the metal oxide, whereby a reactive organosilane is formed on the upper surface of the second thin metal film. The organosilanes used typically have a reactive silane moiety and an organic substituent (i.e., trichloro-organosilanes). The terms “functionalized” and “inert” when used in connection with “organosilane” refers to the organic substituent of the silane and not the silane moiety. Another embodiment is a process comprising: a) depositing a first metal film on a substrate; b) depositing second thin metal film on the first metal film; c) converting the upper surface of the second thin metal film to the corresponding metal oxide; d) reacting an inert organosilane with the metal oxide; e) patterning the inert organosilane to give a pattern of a plurality of metal oxide spots surrounded by inert organosilane; and f) reacting a functionalized organosilane with the metal oxide, whereby a reactive organosilane is formed in the metal oxide spots on the second thin metal film. Another embodiment is a process comprising: a) depositing a first metal film on a substrate; b) depositing a second thin metal film on the first metal film; c) converting the upper surface of the second thin metal film to the corresponding metal oxide; d) applying a patterned photoresist on the upper surface defining a plurality of spots, the upper surface being exposed between spots; e) reacting an inert organosilane on the metal oxide of the upper surface; f) removing the photoresist to form a plurality of metal oxide spots; and g) reacting a functionalized organosilane with the metal oxide, whereby a reactive organosilane is formed in the metal oxide spots. A similar embodiment is a process comprising: a) depositing a first metal film on a substrate; b) depositing second thin metal film on the first metal film; c) patterning a photoresist on the upper surface into a plurality of spots, the surface of the second thin metal film being exposed between spots; d) converting the surface of the second thin metal film between spots to a metal oxide; e) reacting an inert organosilane with the metal oxide of the second thin metal film; f) removing the photoresist to form a plurality of spots comprising the surface of the second thin metal film; g) converting the surface of the second thin metal film in the spots into a metal oxide, whereby a plurality of metal oxide spots is formed; and h) reacting a functionalized organosilane with the metal oxide spots, whereby a reactive organosilane is formed in the metal oxide spots on the second thin metal film.
Another embodiment is a method, comprising a) providing an article including: i) a substrate; ii) a first metal film overlying the substrate; iii) a second thin metal film overlying the first metal film; iv) an organosilane covalently bonded to the exposed upper surface of the second thin metal film through metal-oxygen-silicon bonds; v) a binding group attached to the organosilane; b) contacting the article with a biomolecule; and c) determining whether or not the biomolecule is bound to the binding group by detecting or measuring a surface plasmon resonance signal generated from the first metal film.
One embodiment is an article comprising: a) a substrate; b) a first metal film overlying the substrate; c) a second thin metal film overlying the first metal film; and d) a reactive organosilane covalently bonded to the upper surface of the second thin metal film through metal-oxygen-silicon bonds. The first metal film may be gold, silver, or copper and the second thin metal film may be Ti, Zr, Al, Cr, Hf, V, Ta, W, or Pb. Typically, the first metal film can generate surface plasmons and the upper surface of the second metal film is used to form chemically stable bonds to the reactive organosilane. When the second thin metal film is sufficiently thin, the evanescent wave of the surface plasmons generated by the first metal film extend through the second thin metal film and can be used to detect chemical changes near the upper surface of the second thin metal film. Detecting these chemical changes can be used, for example, to monitor biological molecule binding and image dielectric thin films. Typically, the substrate is glass or quartz. In other embodiments, the substrate comprises one face of a prism. The article may further comprise an adhesion metal layer between the substrate and the first metal film. The adhesion metal layer typically is Cr, Ti, W, or any combination thereof.
In many embodiments, the reactive organosilane has a pattern on the surface that is a plurality of spots. In most embodiments, the spots are arranged in a microarray. Hydrophobic material may surround one or more of the reactive organosilane spots. The hydrophobic material may cause a polar liquid (e.g., water) to bead on the reactive organosilane spot, which allows the spot to be used as a microwell. The size of each spot is typically 10-1000 μm in diameter, and the density of spots is typically 100 to 1 million spots per square centimeter. The hydrophobic material typically comprises an inert organosilane covalently bonded to the upper surface of the second thin metal film through metal-oxygen-silicon bonds. The inert organosilane may include, for example, a fluorinated alkyl group. In many embodiments, the reactive organosilane comprises hydroxy groups. The hydroxy groups may be capped with DNA or RNA (e.g., DNA or RNA have been reacted with the hydroxyl groups to form covalent bonds). An example of a reactive organosilane comprises the structure
wherein: R is a reactive group and n=1-20. The reactive group R may comprise, for example, the structures
wherein m=1-10. One example of an inert organosilane comprises the structure
wherein: q=1-4; and p=1-20. In some embodiments, the reactive organosilane comprises the structure
and the hydrophobic material comprises the structure
wherein: R is a reactive group; X is independently at each occurrence a hydrogen or halogen; n=1-20; and q=1-20. The reactive group R may be as described above. The distance between the upper surface of the second thin metal film and the reactive group R on the reactive organosilane, and the distance between the upper surface of the second thin metal film and the non-bonded terminus of the hydrophobic material are controlled through the appropriate selection of alkyl (—(CH2)n—), or haloalkyl (—(CX2)q—, where X is a halogen) chain lengths.
Another embodiment is a process comprising: a) depositing a first metal film on a substrate; b) depositing a second thin metal film on the first metal film; c) converting the upper surface of the second thin metal film to the corresponding metal oxide; and d) reacting a functionalized organosilane with the metal oxide, whereby a reactive organosilane is formed on the upper surface of the second thin metal film. The first metal film, the second thin metal film, and the substrate may be as described above. In many embodiments, converting the upper surface of the second thin metal film to the corresponding metal oxide comprises oxygen plasma treatment. In one embodiment, the functionalized organosilane is
wherein: R3 is chlorine or alkoxy; p=1-20; and the reactive organosilane comprises
In other embodiments, the reactive organosilane is
and the process further comprises converting the reactive organosilane to
In some embodiments, the process further comprises patterning the reactive organosilane into a plurality of spots. In one embodiment, the process further comprises reacting the reactive organosilane with DNA or RNA.
Another embodiment is a process comprising: a) depositing a first metal film on a substrate; b) depositing a second thin metal film on the first metal film; c) converting the upper surface of the second thin metal film to the corresponding metal oxide; d) reacting an inert organosilane on the upper surface of the second thin metal film; e) patterning the inert organosilane to give a pattern of a plurality of metal oxide spots surrounded by inert organosilane; and f) reacting a functionalized organosilane with the metal oxide, whereby a reactive organosilane is formed in the metal oxide spots on the second thin metal film. Another embodiment is a process comprising: a) depositing a first metal film on a substrate; b) depositing a second thin metal film on the first metal film; c) converting the upper surface of the second thin metal film to the corresponding metal oxide; d) patterning a photoresist on the upper surface into a plurality of spots, the upper surface being exposed between spots; e) reacting an inert organosilane on the metal oxide of the upper surface; f) removing the photoresist to form a plurality of metal oxide spots; and g) reacting a functionalized organosilane with the metal oxide, whereby a reactive organosilane is formed in the metal oxide spots. A similar embodiment is a process comprising: a) depositing a first metal film on a substrate; b) depositing second thin metal film on the first metal film; c) patterning a photoresist on the upper surface into a plurality of spots, the surface of the second thin metal film being exposed between spots; d) converting the surface of the second thin metal film between spots to a metal oxide; e) reacting an inert organosilane with the metal oxide of the second thin metal film; f) removing the photoresist to form a plurality of spots comprising the surface of the second thin metal film; g) converting the surface of the second thin metal film in the spots into a metal oxide, whereby a plurality of metal oxide spots is formed; and h) reacting a functionalized organosilane with the metal oxide spots, whereby a reactive organosilane is formed in the metal oxide spots on the second thin metal film. The substrate, the first metal film, and the second thin metal film may be as described above. The inert organosilane typically includes a fluorinated alkyl group, for example the structure
wherein: q=1-4; and p=1-20. The functionalized organosilane and the reactive organosilane may be as described above. In one embodiment, the reactive organosilane is
and the process further comprises converting the reactive organosilane to
The size of each spot is typically 10-1000 μm in diameter, and the number the density of spots is typically 100 to 1 million spots per square centimeter. The distance between the upper surface of the second thin metal film and the reactive group R on the reactive organosilane, and the distance between the upper surface of the second thin metal film and the non-bonded terminus of the hydrophobic material are controlled through the appropriate selection of alkyl (—(CH2)n—), or haloalkyl (—(CX2)q—, where X is a halogen) chain lengths.
Another embodiment is a method, comprising a) providing an article including: i) a substrate; ii) a first metal film overlying the substrate; iii) a second thin metal film overlying the first metal film; iv) an organosilane covalently bonded to the upper surface of the second thin metal film through metal-oxygen-silicon bonds; and v) a binding group attached to the organosilane; and b) determining whether or not the biomolecule is bound to the binding group by detecting or measuring a surface plasmon resonance signal generated from the first metal film. In some embodiments, the binding group comprises DNA or RNA. The biomolecule is typically DNA, RNA, or a protein. In other embodiments, the binding group is an antigen, an antibody, or a hapten. The organosilane may have a pattern of a plurality of spots. The spots may be arranged in a microarray. The size of each spot is typically 10-1000 μm in diameter, and the number the density of spots is typically 100 to 1 million spots per square centimeter. The first metal film, the second thin metal film, and the glass substrate may be as described above.
The following example(s) is illustrative and does not limit the Claims.
A glass substrate was cleaned using Diamaflow 688C. The substrate was soaked in a 1% solution of Diamaflow 688C in DI-water (18MΩ) with and sonicated for 5 minutes. After sonication, the samples were brushed in a fresh solution of Diamaflow and DI-water and sonicated again in DI-water at 30° C. in 15 minutes. The substrate was rinsed for 5 minutes and dried with filtered N2 gas. Before the metal deposition the substrate was treated with high pressure O2 plasma for 5 minutes. The plasma cleaning process should happen right before the metal deposition otherwise the surface conditions cannot be precisely controlled. The metal deposition was performed in a Denton Discovery 18 DC magnetron sputtering machine. The base pressure was less than 2×10−7 Torr. Argon was used as process gas at a pressure of 7.5 mTorr during deposition. The magnetron current was set to 250 mA. First, a 2 nm thick adhesion layer of Cr was deposited followed by deposition of a 47 nm Au layer, followed by deposition of a 10 nm thick layer of Ti.
Deposition of the inert hydrophobic organosilane and reactive organosilane are shown schematically in cross section in
The present application is a divisional of copending U.S. patent application Ser. No. 11/296,659, filed on Dec. 6, 2005; which application is incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
3105902 | Ostrofsky | Oct 1963 | A |
3751587 | Insler | Aug 1973 | A |
3891507 | Breuer | Jun 1975 | A |
3990850 | Friedman | Nov 1976 | A |
4038030 | Albright | Jul 1977 | A |
4148057 | Jesse | Apr 1979 | A |
4375025 | Carlson | Feb 1983 | A |
4585931 | Duncan | Apr 1986 | A |
4638144 | Latta | Jan 1987 | A |
4707722 | Folk | Nov 1987 | A |
4719502 | Ikeya | Jan 1988 | A |
4753863 | Spanjer | Jun 1988 | A |
4789804 | Karube | Dec 1988 | A |
4861620 | Azuma | Aug 1989 | A |
4945045 | Forrest | Jul 1990 | A |
4945204 | Nakamura | Jul 1990 | A |
4997278 | Finlan | Mar 1991 | A |
5030551 | Herren | Jul 1991 | A |
5068124 | Batey | Nov 1991 | A |
5078855 | Mochizuki | Jan 1992 | A |
5089112 | Skotheim | Feb 1992 | A |
5104619 | de Castro | Apr 1992 | A |
5116481 | Ozawa | May 1992 | A |
5157412 | Kleinschmick | Oct 1992 | A |
5192507 | Taylor | Mar 1993 | A |
5200051 | Cozzette | Apr 1993 | A |
5206280 | Williams | Apr 1993 | A |
5242828 | Bergstrom | Sep 1993 | A |
5246846 | Pittner | Sep 1993 | A |
5262470 | Shimotsuma | Nov 1993 | A |
5268305 | Ribi | Dec 1993 | A |
5313264 | Ivarsson | May 1994 | A |
5329090 | Woelki | Jul 1994 | A |
5346802 | Ohbachi | Sep 1994 | A |
5357077 | Tsuruta | Oct 1994 | A |
5368712 | Tomich | Nov 1994 | A |
5373039 | Sakai | Dec 1994 | A |
5401378 | King | Mar 1995 | A |
5405783 | Pirrung | Apr 1995 | A |
5413629 | Yasui | May 1995 | A |
5415838 | Rieger | May 1995 | A |
5436161 | Bergstrom | Jul 1995 | A |
5436170 | Cornell | Jul 1995 | A |
5445923 | Takahashi | Aug 1995 | A |
5445934 | Fodor et al. | Aug 1995 | A |
5474796 | Brennan | Dec 1995 | A |
5478756 | Gizeli | Dec 1995 | A |
5485277 | Foster | Jan 1996 | A |
5491097 | Ribi | Feb 1996 | A |
5492840 | Malmqvist | Feb 1996 | A |
5512131 | Kumar | Apr 1996 | A |
5514501 | Tarlov | May 1996 | A |
5527711 | Tom-Moy | Jun 1996 | A |
5536822 | Haystead | Jul 1996 | A |
5567301 | Stetter | Oct 1996 | A |
5571568 | Ribi | Nov 1996 | A |
5580794 | Allen | Dec 1996 | A |
5622872 | Ribi | Apr 1997 | A |
5624537 | Turner | Apr 1997 | A |
5629790 | Neukermans | May 1997 | A |
5637201 | Raguse | Jun 1997 | A |
5688642 | Chrisey | Nov 1997 | A |
5693477 | Cornell | Dec 1997 | A |
5707502 | McCaffrey | Jan 1998 | A |
5716778 | Weng | Feb 1998 | A |
5719060 | Hutchens | Feb 1998 | A |
5723345 | Yamauchi | Mar 1998 | A |
5736410 | Zarling | Apr 1998 | A |
5741409 | Raguse | Apr 1998 | A |
5753093 | Raguse | May 1998 | A |
5756355 | Lang | May 1998 | A |
5783054 | Raguse | Jul 1998 | A |
5798030 | Raguse | Aug 1998 | A |
5824483 | Housten | Oct 1998 | A |
5834224 | Ruger | Nov 1998 | A |
5844099 | Stahl | Dec 1998 | A |
5846842 | Herron | Dec 1998 | A |
5922594 | Lof | Jul 1999 | A |
5922617 | Wang | Jul 1999 | A |
5938595 | Glass | Aug 1999 | A |
5942388 | Willner | Aug 1999 | A |
5955379 | Lennox | Sep 1999 | A |
5985377 | Corbet | Nov 1999 | A |
6020208 | Hutchens | Feb 2000 | A |
6027942 | Hutchens | Feb 2000 | A |
6040193 | Winkler et al. | Mar 2000 | A |
6054270 | Southern | Apr 2000 | A |
6074616 | Beuchler | Jun 2000 | A |
6096825 | Garnier | Aug 2000 | A |
6101946 | Martinsky | Aug 2000 | A |
6113992 | Corbet | Sep 2000 | A |
6146593 | Pinkel | Nov 2000 | A |
6150147 | Goldberg et al. | Nov 2000 | A |
6165335 | Lennox et al. | Dec 2000 | A |
6197599 | Chin | Mar 2001 | B1 |
6217949 | Corbet | Apr 2001 | B1 |
6218111 | Southern et al. | Apr 2001 | B1 |
6218194 | Lyndin | Apr 2001 | B1 |
6219138 | Swanson | Apr 2001 | B1 |
6225047 | Hutchens | May 2001 | B1 |
6225625 | Pirrung et al. | May 2001 | B1 |
6232066 | Felder | May 2001 | B1 |
6245590 | Wine | Jun 2001 | B1 |
6261776 | Pirrung et al. | Jul 2001 | B1 |
6291155 | Raguse | Sep 2001 | B1 |
6291183 | Pirrung et al. | Sep 2001 | B1 |
6309831 | Goldberg et al. | Oct 2001 | B1 |
6322970 | Little | Nov 2001 | B1 |
6329209 | Wagner | Dec 2001 | B1 |
6340597 | Svorc | Jan 2002 | B1 |
6346413 | Fodor et al. | Feb 2002 | B1 |
6362912 | Lewis | Mar 2002 | B1 |
6379929 | Burns | Apr 2002 | B1 |
6380365 | Akerstrom | Apr 2002 | B1 |
6399365 | Besemer et al. | Jun 2002 | B2 |
6406921 | Wagner | Jun 2002 | B1 |
6416952 | Pirrung et al. | Jul 2002 | B1 |
6421164 | Tearney | Jul 2002 | B2 |
6433907 | Lippert | Aug 2002 | B1 |
6447723 | Schermer | Sep 2002 | B1 |
6448065 | Laugharn | Sep 2002 | B2 |
6448089 | Vuong | Sep 2002 | B1 |
6461490 | Lennox et al. | Oct 2002 | B1 |
6472179 | Stahl | Oct 2002 | B2 |
6478939 | Lennox et al. | Nov 2002 | B1 |
6482593 | Walt | Nov 2002 | B2 |
6485918 | Schermer | Nov 2002 | B1 |
6489106 | Shivashankar | Dec 2002 | B1 |
6491871 | Fodor et al. | Dec 2002 | B1 |
6545758 | Sandstrom | Apr 2003 | B1 |
6548171 | Barbera-Guillem | Apr 2003 | B1 |
6558623 | Ganz | May 2003 | B1 |
6565813 | Garyantes | May 2003 | B1 |
6569385 | Little | May 2003 | B1 |
6576424 | Fodor et al. | Jun 2003 | B2 |
6576426 | Southern et al. | Jun 2003 | B2 |
6586193 | Yguerabide | Jul 2003 | B2 |
6600031 | Fodor et al. | Jul 2003 | B1 |
6610482 | Fodor et al. | Aug 2003 | B1 |
6733977 | Besemer et al. | May 2004 | B2 |
6785433 | Tiefenthaler | Aug 2004 | B2 |
6787368 | Wong | Sep 2004 | B1 |
6789040 | Kaushikkar | Sep 2004 | B2 |
6800453 | Labaer et al. | Oct 2004 | B2 |
6806361 | Kajisa et al. | Oct 2004 | B1 |
6862094 | Johansen | Mar 2005 | B2 |
6870627 | Elkind | Mar 2005 | B2 |
6902705 | Caillat | Jun 2005 | B1 |
6911344 | Reichert | Jun 2005 | B1 |
6980294 | Namba | Dec 2005 | B2 |
6999175 | Ivarsson | Feb 2006 | B2 |
7041208 | Staats | May 2006 | B2 |
7081954 | Sandstrom | Jul 2006 | B2 |
7084980 | Jones et al. | Aug 2006 | B2 |
7126688 | Rassman | Oct 2006 | B2 |
7251085 | Bahatt et al. | Jul 2007 | B2 |
7312069 | Ban | Dec 2007 | B2 |
7319046 | Misiakos | Jan 2008 | B2 |
7463358 | Wolf et al. | Dec 2008 | B2 |
20020024495 | Lippert | Feb 2002 | A1 |
20020044893 | Corn | Apr 2002 | A1 |
20020068813 | Dragic | Jun 2002 | A1 |
20020127565 | Cunningham | Sep 2002 | A1 |
20020140938 | Naya | Oct 2002 | A1 |
20020197729 | Tsuzuki | Dec 2002 | A1 |
20030082820 | Perbost | May 2003 | A1 |
20030100004 | Kurz | May 2003 | A1 |
20030107741 | Pyo | Jun 2003 | A1 |
20030143576 | Chao et al. | Jul 2003 | A1 |
20040008345 | Nurmikko | Jan 2004 | A1 |
20040014946 | Chao | Jan 2004 | A1 |
20040043384 | Oleinikov | Mar 2004 | A1 |
20040048311 | Ault-Riche | Mar 2004 | A1 |
20040067597 | Datwani | Apr 2004 | A1 |
20040161748 | He et al. | Aug 2004 | A1 |
20040174518 | Naiki | Sep 2004 | A1 |
20040198637 | Schultz et al. | Oct 2004 | A1 |
20040214233 | Lubman | Oct 2004 | A1 |
20040248144 | Mir | Dec 2004 | A1 |
20040258832 | Barklund et al. | Dec 2004 | A1 |
20050002085 | Matsui | Jan 2005 | A1 |
20050014179 | Karlsson et al. | Jan 2005 | A1 |
20050046848 | Cromwell | Mar 2005 | A1 |
20050095577 | Yang | May 2005 | A1 |
20050200845 | Nabatova-Gabain et al. | Sep 2005 | A1 |
20060091051 | Takada | May 2006 | A1 |
20060134669 | Casasanta | Jun 2006 | A1 |
20060154320 | Zuk | Jul 2006 | A1 |
20060187459 | Ok | Aug 2006 | A1 |
20060234265 | Richey et al. | Oct 2006 | A1 |
20070009198 | Petcavich | Jan 2007 | A1 |
20070059817 | Aoyagi | Mar 2007 | A1 |
20070081163 | Liang et al. | Apr 2007 | A1 |
20070099180 | Robotti et al. | May 2007 | A1 |
20070122314 | Strand | May 2007 | A1 |
20070128455 | Wolf | Jun 2007 | A1 |
20070139653 | Guan et al. | Jun 2007 | A1 |
20070140918 | Yin | Jun 2007 | A1 |
20070222996 | Guan et al. | Sep 2007 | A1 |
20090060786 | Kim et al. | Mar 2009 | A1 |
20090060787 | Kim et al. | Mar 2009 | A1 |
Number | Date | Country |
---|---|---|
10064146 | Dec 2000 | DE |
WO 9315110 | Aug 1993 | WO |
WO 9531480 | Nov 1995 | WO |
WO 9602830 | Feb 1996 | WO |
WO 9609547 | Mar 1996 | WO |
WO 9707593 | Jan 1997 | WO |
WO 9741424 | Jan 1997 | WO |
WO 9741425 | Jan 1997 | WO |
WO 9712988 | Apr 1997 | WO |
WO 02052260 | Jul 2002 | WO |
Number | Date | Country | |
---|---|---|---|
20090093067 A1 | Apr 2009 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11296659 | Dec 2005 | US |
Child | 12330384 | US |